Sickle Cell Trait Management

Understanding the Condition

• The Association of Anaesthetists states that sickle cell trait is a "mostly benign condition" that only becomes clinically important at extremes of physiology such as severe sepsis, prolonged hypoxia, or severe dehydration, and is not considered further in their comprehensive guidelines on managing sickle cell complications 1
• Sickle cell trait (HbAS) is fundamentally different from sickle cell disease, representing the heterozygous carrier state where individuals have one normal hemoglobin gene and one sickle hemoglobin gene 1

Clinical Implications

• The approximately 240,000 healthy carriers with sickle cell trait in the UK do not require the specialized perioperative management, transfusion protocols, or crisis prevention strategies needed for patients with actual sickle cell disease 1
• Sickle cell trait carriers can develop acute ischemic complications under specific extreme conditions, such as severe sepsis 1